BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22977124)

  • 1. Lives saved by breast screening outnumber cases of overdiagnosis, review says.
    Hawkes N
    BMJ; 2012 Sep; 345():e6155. PubMed ID: 22977124
    [No Abstract]   [Full Text] [Related]  

  • 2. Absolute numbers of lives saved and overdiagnosis in breast cancer screening.
    Junod B; Spinosa JP
    J Med Screen; 2010; 17(2):103; author reply 103. PubMed ID: 20660442
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer screening: one life saved at a cost of three overdiagnosis.
    BMJ; 2012 Nov; 345():e7460. PubMed ID: 23129492
    [No Abstract]   [Full Text] [Related]  

  • 4. [Population-based breast cancer screening is not worthwhile. Screening has little effect on mortality].
    Bonneux LG; Autier P
    Ned Tijdschr Geneeskd; 2011; 155(35):A3774. PubMed ID: 21902850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme.
    Molins E; Comas M; Román R; Rodríguez-Blanco T; Sala M; Macià F; Murta-Nascimento C; Castells X
    Public Health; 2009 Sep; 123(9):635-7. PubMed ID: 19733372
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast screening: fundamental errors in estimate of lives saved by screening.
    Jørgensen KJ; Gøtzsche PC
    BMJ; 2009 Aug; 339():b3359. PubMed ID: 19706654
    [No Abstract]   [Full Text] [Related]  

  • 7. Some issues in screening for breast and other cancers.
    Duffy SW; McCann J; Godward S; Gabe R; Warwick J
    J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive mammographic screening: factors influencing re-attendance over a decade of screening.
    Fitzpatrick P; Fleming P; O'Neill S; Kiernan D; Mooney T
    J Med Screen; 2011; 18(1):30-3. PubMed ID: 21536814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening for women 40 to 49 years of age: what is a clinician to do?
    Gemignani ML
    Obstet Gynecol; 2007 Sep; 110(3):548-9. PubMed ID: 17766597
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer screening--when do we start and how often should it be done?
    Fenton A; Panay N
    Climacteric; 2011 Oct; 14(5):513-4. PubMed ID: 21910669
    [No Abstract]   [Full Text] [Related]  

  • 11. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Population screening: there are no certainties].
    Roukema JA
    Ned Tijdschr Geneeskd; 2013; 156(0):A5384. PubMed ID: 24330786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population screening for breast cancer by mammography in The Netherlands. Expectations, early results, negative effects and conditions for large-scale screening.
    Hendriks JH; Verbeek AL
    Diagn Imaging Clin Med; 1985; 54(3-4):186-91. PubMed ID: 3896616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases.
    Seigneurin A; Exbrayat C; Labarère J; Delafosse P; Poncet F; Colonna M
    Breast Cancer Res Treat; 2011 May; 127(1):221-8. PubMed ID: 20809364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Section editor's notebook: breast cancer screening and overdiagnosis unmasked.
    Javitt MC
    AJR Am J Roentgenol; 2014 Feb; 202(2):259-61. PubMed ID: 24450663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of mammographic screening at the Mammary Center of Debrecen in 1999 and 2000].
    Simon E; Péter M; Benkó K; Horkay E; Erdélyi G; Péter M; Szúcs-Farkas Z; Tóth J; Kovács I; Fülöp B
    Orv Hetil; 2002 Apr; 143(14):721-3. PubMed ID: 11975392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for breast cancer.
    Garr DR
    Am Fam Physician; 2000 Aug; 62(3):500-1. PubMed ID: 10950208
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting the risk of a false-positive test for women following a mammography screening programme.
    Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mass screening for breast cancer: remaining questions].
    Verbeek AL
    Ned Tijdschr Geneeskd; 1987 Sep; 131(37):1602-4. PubMed ID: 3670448
    [No Abstract]   [Full Text] [Related]  

  • 20. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.